ADMA Valuation
ADMA Biologics Inc
$
23.520
- Overview
- Forecast
- Valuation
ADMA Relative Valuation
ADMA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ADMA is overvalued; if below, it's undervalued.
Historical Valuation
ADMA Biologics Inc (ADMA) is now in the Overvalued zone, suggesting that its current forward PS ratio of 11.20 is considered Overvalued compared with the five-year average of 4.08. The fair price of ADMA Biologics Inc (ADMA) is between 6.05 to 14.10 according to relative valuation methord. Compared to the current price of 23.52 USD , ADMA Biologics Inc is Overvalued By 66.82%.
Relative Value
Fair Zone
6.05-14.10
Current Price：23.52
66.82%
Overvalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
15.78
P/B
Median3y
9.44
Median5y
6.58
1.99
FCF Yield
Median3y
-6.40
Median5y
-24.47
Competitors Valuation Multiple
The average P/S ratio for ADMA's competitors is 6.66, providing a benchmark for relative valuation. ADMA Biologics Inc Corp (ADMA) exhibits a P/S ratio of 11.20, which is 68.02% above the industry average. Given its robust revenue growth of 59.06%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
HAIN
Hain Celestial Group Inc
3.030
USD
+3.77%
DCGO
DocGo Inc
2.310
USD
+5.00%
CYH
Community Health Systems Inc
2.830
USD
+2.54%
ITIC
Investors Title Co
240.680
USD
+3.26%
PRTC
PureTech Health PLC
17.550
USD
-0.62%
DDD
3D Systems Corp
2.010
USD
+6.35%
ORKA
Oruka Therapeutics Inc
10.710
USD
+6.14%
ATXS
Astria Therapeutics Inc
5.360
USD
+3.88%
ACTG
Acacia Research Corp
3.160
USD
+0.32%
JILL
JJill Inc
15.860
USD
+2.12%
FAQ
Is ADMA Biologics Inc (ADMA) currently overvalued or undervalued?
ADMA Biologics Inc (ADMA) is now in the Overvalued zone, suggesting that its current forward PE ratio of 34.99 is considered Overvalued compared with the five-year average of 4.08. The fair price of ADMA Biologics Inc (ADMA) is between 6.05 to 14.10 according to relative valuation methord. Compared to the current price of 23.52 USD , ADMA Biologics Inc is Overvalued By 66.82% .
What is ADMA Biologics Inc (ADMA) fair value?
How does ADMA's valuation metrics compare to the industry average?
What is the current P/B ratio for ADMA Biologics Inc (ADMA) as of May 03 2025?
What is the current FCF Yield for ADMA Biologics Inc (ADMA) as of May 03 2025?
What is the current Forward P/E ratio for ADMA Biologics Inc (ADMA) as of May 03 2025?